Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Randall Given is active.

Publication


Featured researches published by Randall Given.


Cancer | 2005

Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression

Stephanie L. Cowey; Michael J. Quast; Ligia Maria Belalcazar; Jingwa Wei; B S Xiaoling Deng; Randall Given; Pomila Singh

The authors recently reported that gastrin gene knockout (GAS‐KO) mice had an increased risk for colon carcinogenesis in response to azoxymethane (AOM) compared with their wild type (WT) littermates. In the current report, the authors discuss the predisposition of GAS‐KO mice to develop obesity and metabolic hormonal changes that may contribute to their increased risk of colon carcinogenesis.


Journal of Histochemistry and Cytochemistry | 2006

Effects of progesterone on iNOS, COX-2, and collagen expression in the cervix.

Stephen Marx; Melissa J. Wentz; Lynette Mackay; Dietmar Schlembach; Holger Maul; Cordula Fittkow; Randall Given; Y. P. Vedernikov; George R. Saade; Robert E. Garfield

This study examines the relationship between inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in the control of cervical ripening and parturition under normal (normal term pregnancy) and abnormal (preterm labor and prolongation of pregnancy) conditions by (a) measuring changes in the collagen both visually and quantitatively, (b) localizing and characterizing iNOS and COX-2 under normal conditions, and (c) characterizing the changes in iNOS and COX-2 under abnormal conditions. Cervices are obtained from estrus and timed pregnant Sprague-Dawley rats (n=4-10 per group). Preterm labor is induced with Onapristone (3 mg/rat; progesterone antagonist) and the prolongation of pregnancy with progesterone (2.5 mg, twice daily). Collagen changes are measured and visualized with the picrosirius polarization method. RT-PCR is used to characterize the mRNA expression (p<0.5), and immunohistochemistry is used to localize the protein expression for iNOS and COX-2. The organization and birefringence of the collagen during pregnancy decreased and is supported by changes in the luminosity (p<0.001). The iNOS and COX-2 enzymes were localized in cervical smooth muscle, vascular smooth muscle, and epithelium. Under normal conditions, iNOS mRNA levels decreased as COX-2 mRNA levels increased demonstrating an inverse correlation (Spearman r = −0.497; p=0.00295). Onapristone stimulated preterm labor, increasing the iNOS and COX-2 mRNA (p<0.05). The increase demonstrated a positive correlation (Spearman r = 0.456; p=0.03). Progesterone prolonged pregnancy, decreasing the iNOS and COX-2 mRNA (p=0.036). In conclusion, there may be an interaction between the nitric oxide and prostaglandin pathways in cervical ripening and parturition.


Peptides | 2003

Binding of cationic cell-permeable peptides to plastic and glass

Diane E. Chico; Randall Given; Brian T. Miller

Cell-penetrating peptides derived from hydrophilic regions of the homeoprotein Antennapedia (Antp) or the transcription-regulating factor Tat have been used to transport several peptide and oligonucleotide cargoes into the interior of cells. Such vector peptides penetrate cells, in part, because they contain multiple lysine and arginine residues. Using radiolabeled peptide cargoes covalently linked to Antp- or Tat-related vectors, or to D-Arg heptamers, we found that a significant amount of the label remained tightly bound to plastic and glass surfaces. Binding of the labeled conjugates was due entirely to the cationic vector moieties. Under certain conditions, such non-specific binding could be mistaken for cellular penetration.


Steroids | 2003

Synergistic effects of antiprogestins and iNOS or aromatase inhibitors on establishment and maintenance of pregnancy.

Leili Shi; Shao Qing Shi; Randall Given; Helena von Hertzen; Robert E. Garfield

Progesterone is known to be involved in many steps in female reproduction including control of implantation and uterine-cervical function during pregnancy. Our studies in rats and guinea pigs indicate that progesterone inhibits uterine contractility and cervical softening during pregnancy. Progesterone levels or actions decline near the end of pregnancy leading to the onset of labor. Treatment with progestin agonists prolongs pregnancy and inhibits cervical softening, whereas treatment with antiprogestins (mifepristone or onapristone) stimulates uterine contractility, cervical softening and premature delivery. Thus the effect of progesterone receptor modulators in the uterus and cervix depend up on the degree of intrinsic agonistic/antagonistic activities. Our recent studies show that progesterone interacts with nitric oxide (NO) to maintain pregnancy and that administration of progesterone antagonists with NO synthase inhibitors act synergistically to stimulate labor. In addition our studies show that combinations of progesterone antagonists with aromatase inhibitors act synergistically to induce labor. Similarly antiprogestins interact with NO synthase or aromatase inhibitors to block implantation through action on the endometrium. These studies suggest new applications for combined therapies of progestin receptor modulators with aromatase inhibitors or agents that modify NO production for contraception, stimulation of labor, estrogen-dependent diseases and improved outcomes in pregnancy.


Gastroenterology | 1998

Differential activation of IGF-II promoters P3 and P4 in Caco-2 cells during growth and differentiation

Pomila Singh; Bosong Dai; Randall Given; Xianbin Lu; P. Elly Holthuizen

BACKGROUND & AIMS Insulin-like growth factor (IGF)-II gene is overexpressed in colon cancers. Transcriptional up-regulation may be the major mechanism contributing to its overexpression. IGF-II messenger RNA (mRNA) levels are up-regulated during proliferation followed by a significant decline during differentiation of Caco-2 cells. Mechanisms underlying transcriptional regulation of the IGF-II gene promoters (P1-P4) have yet to be examined in colon cancers, which was the basis for this study. METHODS Ribonuclease protection assay was used to measure IGF-II mRNA derived from P1-P4. To determine if changes in the IGF-II transcripts reflected differences in promoter activity, transient transfection assays with the full-length P1-P4-luciferase expression vectors were performed. RESULTS Both P3- and P4-derived transcripts were significantly up-regulated during the proliferative phase of the cells (days 3-6 in culture) and declined rapidly in cells undergoing differentiation (days 7-10); conversely, P1- and P2-derived transcripts were not detected. Similarly, transcriptional activity of P3 and P4 promoters reached peak levels by days 4-6 and declined rapidly thereafter. P1 and P2 were relatively inactive on all days. CONCLUSIONS The activity of the P3 and P4 promoters may play a selective role in regulating IGF-II mRNA levels during growth and differentiation of colon cancer cells.


Gastroenterology | 2001

Full-length, unprocessed, progastrin peptide (PG) exerts proliferative effects on colonic mucosa of mice via high affinity binding sites, that are specific for gastrin-like peptides with negligible affinity for cholecystokinin

Stephanie Cobb; Azar Owlia; Xian B. Lu; Randall Given; Marco Velasco; Brian T. Miller; Andrea Varro; Pomila Singh

fluid secretion by 71.7 % (p<O.05), epithelial cell damage by 56%, (p<O.05), mucosal congestion and edema by 26% (p<O.O5), and neutrophil infiltration by 60.8%, (p<O.O01). None of the CRH antagonists had any effect on basal fluid secretion. Conclusions: CRH plays a significant proinflammatory role in TxAinduced intestinal secretion and inflammation and the CRH receptor 1, at least in part, participates in the mediation of these responses. These findings may be important in the treatment of gut inflammation in view of the recent development of CRH receptor antagonists. Supported by the Crohns and Colitis Foundation of America, Inc., and the National Institutes of Hea~th (DK 33506).


Gastroenterology | 2000

Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen.

Pomila Singh; Marco Velasco; Randall Given; Andrea Varro; Timothy C. Wang


Clinical Anatomy | 1994

Status of gross anatomy in the U.S. and Canada: Dilemma for the 21st century

Thomas J. Collins; Randall Given; Claire E. Hulsebosch; Brian T. Miller


Molecular Human Reproduction | 1999

Nitric oxide synthase distribution during implantation in the mouse

T. L. Purcell; Randall Given; Kristof Chwalisz; Robert E. Garfield


American Journal of Physiology-gastrointestinal and Liver Physiology | 2000

Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM

Pomila Singh; Marco Velasco; Randall Given; Michael J. Wargovich; Andrea Varro; Timothy C. Wang

Collaboration


Dive into the Randall Given's collaboration.

Top Co-Authors

Avatar

Pomila Singh

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Marco Velasco

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Robert E. Garfield

St. Joseph's Hospital and Medical Center

View shared research outputs
Top Co-Authors

Avatar

Andrea Varro

University of Liverpool

View shared research outputs
Top Co-Authors

Avatar

Stephanie Cobb

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Brian T. Miller

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Thomas G. Wood

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Thomas N. Blankenship

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Timothy C. Wang

University of Massachusetts Amherst

View shared research outputs
Top Co-Authors

Avatar

Azar Owlia

University of Texas Medical Branch

View shared research outputs
Researchain Logo
Decentralizing Knowledge